What is Biogenetics?
Biogenetics Corporation operates as a specialized leader in the cryobanking and fertility laboratory services market. The company provides critical infrastructure for the long-term storage and management of reproductive cells and tissues, including sperm, embryos, and ovarian tissue. By integrating rigorous donor screening protocols with advanced cryopreservation techniques, Biogenetics facilitates a comprehensive suite of services that includes anonymous and ID-accessible donor programs. Furthermore, the firm maintains a robust logistics network for the worldwide distribution of reproductive materials, complemented by specialized urology and laboratory services focused on male fertility evaluation. This multifaceted business model positions Biogenetics as a vital partner for both prospective donors and recipients navigating complex fertility journeys.
How much funding has Biogenetics raised?
Biogenetics has raised a total of $72K across 1 funding round:
Debt
$72K
Debt (2021): $72K with participation from PPP
Key Investors in Biogenetics
PPP
Public-Private Partnership
What's next for Biogenetics?
The infusion of capital is expected to catalyze a phase of aggressive scaling for Biogenetics. As the firm transitions through its current growth stage, strategic priorities will likely include the expansion of its global distribution network and the enhancement of its laboratory infrastructure to meet rising demand for reproductive health services. By leveraging this investment, Biogenetics aims to solidify its market leadership, potentially exploring new technological integrations in cryopreservation and expanding its donor program diversity. The company remains focused on maintaining high-standard compliance and safety protocols, which are essential for sustaining long-term trust and operational excellence in the sensitive field of reproductive medicine.
See full Biogenetics company page
